A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Overview of attention for article published in BMC Medicine, July 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 210 Dimensions

Readers on

mendeley: 144 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER

Application EP-4332240-A1

European Patent Office

METHODS AND ARRAYS FOR USE IN THE SAME

Application EP-3557259-A2

European Patent Office

METHODS AND ARRAYS FOR USE IN THE SAME

Application WO-2014161910-A2

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.